Ca2+ release-activated Ca2+(CRAC) channels are involved in a vast array of cellular responses, and abnormal channel activity has now been linked to many diseases including immunodeficiency and autoimmunity disorders, allergy, and cancer. Here, Parekh discusses recent advances in understanding the molecular basis, gating and function of CRAC channels, as well as the therapeutic potential of CRAC channel inhibitors.
